The month of April was a bit lighter in quantity of hires, but those we did see were high-profile: pharma and biotech saw at least four CEO changes, as well as numerous board chairs.
For our final March hires roundup instalment, we have our “pharma-adjacent” roundup which includes CROs, clinical trial software companies, manufacturing organisations, suppliers, non-profi
Bristol-Myers Squibb’s long-serving chief executive Giovanni Caforio has said he will retire on 1st November after almost eight years in the role and more than two decades
